Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Myomo Inc MYO

Healthcare Medical Devices
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial... see more

Recent & Breaking News (NYSEAM:MYO)

Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock

Business Wire December 5, 2024

Myomo, Inc. Announces Proposed Public Offering of Common Stock

Business Wire December 4, 2024

Myomo Reports Record Third Quarter Financial and Operating Results

Business Wire November 6, 2024

Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage

Business Wire October 31, 2024

Myomo to Report Third Quarter Financial Results on November 6, 2024

Business Wire October 30, 2024

Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit

Business Wire October 9, 2024

Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly

Business Wire September 12, 2024

Myomo to Participate in Two Investor Conferences in September

Business Wire September 5, 2024

Myomo Reports Second Quarter 2024 Financial Results

Business Wire August 6, 2024

Myomo to Report Second Quarter Financial Results on August 6, 2024

Business Wire July 30, 2024

Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics

Business Wire July 8, 2024

Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024

Business Wire June 5, 2024

Myomo Reports First Quarter 2024 Financial Results

Business Wire May 8, 2024

Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees

Business Wire May 6, 2024

Myomo to Report First Quarter Financial Results on May 8, 2024

Business Wire May 1, 2024

Myomo Appoints Heather Getz to its Board of Directors

Business Wire March 28, 2024

Myomo Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire March 7, 2024

CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®

Business Wire March 1, 2024

Myomo to Report Fourth Quarter Financial Results on March 7, 2024

Business Wire February 29, 2024

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Business Wire January 19, 2024